Roster Trends
6

14

11

9

11

10

9

4

6

0
0
1

0
-1

0
0
0
0






123456789101112131415161718192021222324
Fantasy Points by Week. Note: Points are rounded down.
 
Fantasy Games
Fantasy Basketball Commissioner
Our premium game includes customization of scoring and rules, exclusive news and roster tools, and much more. PLAY NOW
Fantasy Basketball Prize Leagues
Use your skill and Fantasy talent to win up to $1,100 in cash prizes. Choose a league based on your level. Entry fee applies. PLAY NOW
 
Key Stats
GPMIN/GPPGREB/GAST/GFG %
8230.010.111.70.954.1
 
Situational Stats
10/30/2013 vs. CHA
SituationGMINREBAPTSAVG
vs. CHA000000
At Home000000
On Road000000
 
Injury Report
Illness - Game Time Decision
(Updated: 20170223)
More Injuries
 
Recent Trades
DateTradedTraded For
01/27/2017Brook Lopez, C BKN
Gary Harris, SG DEN
George Hill, PG UTA
Manu Ginobili, SG SA
Omer Asik, C NO
Joel Embiid, C PHI
 
Last 10 Games
DateOpp.MINPTSTREBATOSTLBLK
01/29WAS0000000
01/31TOR0000000
02/01DET0000000
02/04WAS0000000
02/06PHO0000000
02/08UTA0000000
02/10MIN5010100
02/12SAC0000000
02/13PHO0000000
02/15MEM0000000
 
 
 
Latest News

Pelicans' Omer Asik: Listed as doubtful for Thursday

by RotoWire Staff | Special to CBSSports.com
(2/22/17) Aski is listed as doubtful for Thursday's game against the Rockets with an illness.

Asik has found himself out of the team's regular rotation since mid-December, and with the arrival of DeMarcus Cousins, injury will likely remain the only avenue for Asik to see frontcourt minutes in New Orleans this season. If he is officially ruled out for Thursday's game, his absence will not have any impact on the Pelicans' new rotation.

Pelicans' Omer Asik: Still outside of rotation

by RotoWire Staff | Special to CBSSports.com
(2/13/17) Asik (coach's decision) didn't see the floor in a 105-99 loss to the Kings on Sunday.

Asik has made just three appearances in the Pelicans' 20 games since the beginning of January. The center won't have a place in the team's rotation so long as Anthony Davis is healthy, and even when that's not the case, Asik won't be asked to play more than a few spot minutes. The Pelicans would surely love to trade Asik, but since he's still under contract for three more seasons, he has negative value on the open market.

Pelicans' Omer Asik: Disastrous start against Nets

by RotoWire Staff | Special to CBSSports.com
(1/13/17) Asik scored zero points (0-0 FG) and collected one rebound in 5 minutes Thursday during a 104-95 win over Brooklyn.

Well, that didn't take long. With Anthony Davis (hip) out, Asik got the start against the Nets, and although Dante Cunningham and Terrence Jones were still expected to get the lion's share of frontcourt minutes, Asik bombed out of the game early. He got dunked on, picked up two early fouls and didn't see the court again. Not that he was on anyone's fantasy radar before, but his fantasy value is officially at rock bottom.

Pelicans' Omer Asik: Will start at center Thursday

by RotoWire Staff | Special to CBSSports.com
(1/12/17) Asik will start at center for Thursday's game against the Nets, Daniel Sallerson of Pelicans.com reports.

Anthony Davis is sitting out with a hip injury, so the Pelicans are opting to go back to a big lineup, using Asik at center to matchup with Brook Lopez of the Nets. Asik hasn't seen the floor over the last eight games, so he'll see a pretty significant bump in playing time. That said, it seems more likely that guys like Terrence Jones and Dante Cunningham will benefit the most from Davis' absence, so it may still be a bit too risky to use Asik in DFS contests despite drawing the start.

Pelicans' Omer Asik: Still not included in rotation

by RotoWire Staff | Special to CBSSports.com
(1/10/17) Asik (coach's decision) was a healthy inactive for Monday's 110-96 win over the Knicks.

Since playing nine minutes off the bench Dec. 21 against the Thunder, Asik hasn't played at all, as he's remained glued to the bench for the past eight games. The fact that he was one of the Pelicans' inactives over lightly-used second-round pick Cheick Diallo speaks to how far Asik's stock has fallen since signing a five-year, $57.7 million contract in the summer of 2015. With the Pelicans unlikely to find a trade partner willing to take on Asik's onerous contract, the center will continue to eat up a roster spot better served for another player.

 
 

 
Two Week Schedule
FEBRUARY /MARCH
SunMonTueWedThuFriSat
19
20
21
22
23
HOU
8:00 pm
Tickets
24
25
@DAL
8:30 pm
Tickets
26
@OKC
7:00 pm
Tickets
27
28
1
DET
8:00 pm
Tickets
2
3
SA
9:30 pm
Tickets
4
 
Career Shooting Stats
SeasonTEAMGMINFGFGAFG%FG3FG3AFG3%FTFTAFT%PTSAVG
2010-11Chicago829897814155.3000.07314550.32292.8
2011-12Chicago669717915650.6000.04710345.62053.1
2012-13Houston82246433261454.1010.016829956.283210.1
2013-14Houston4896810119053.2000.07812661.92805.8
2014-15New Orleans76198221341251.7000.013122558.25577.3
2015-16New Orleans68117810419553.3000.06111254.52694.0
2016-17New Orleans31482316547.7000.0233959.0852.7
TOTAL4539035938177352.9010.0581104955.424575.4
More Stats
SeasonTEAMGMINREBRAVGAAAVGSTLSAVGBLKBAVGTO
2010-11Chicago829893063.7320.4200.2560.764
2011-12Chicago669713505.3320.5300.5681.068
2012-13Houston82246495611.7750.9460.6871.1173
2013-14Houston489683787.9250.5140.3370.859
2014-15New Orleans7619827489.8720.9290.4540.795
2015-16New Orleans6811784146.1260.4210.3230.360
2016-17New Orleans314821635.3150.550.2100.314
TOTAL453903533157.32770.61650.43350.7533
Postseason Stats
SeasonTEAMGMINFGFGAFG%FG3FG3AFG3%FTFTAFT%PTSAVG
2010-11Chicago1514861346.2000.031030.0151.0
2011-12Chicago612871450.0000.061735.3203.3
2012-13Houston6208223956.4000.0304763.87412.3
2013-14Houston6163163348.5000.033100.0355.8
2014-15New Orleans47921020.0000.04757.182.0
TOTAL377265310948.6000.0468454.81524.1
More Postseason Stats
SeasonTEAMGMINREBRAVGAAAVGSTLSAVGBLKBAVGTO
2010-11Chicago15148312.110.120.180.57
2011-12Chicago6128284.781.310.2101.78
2012-13Houston62086711.230.530.5101.712
2013-14Houston6163498.240.730.540.711
2014-15New Orleans479297.261.551.200.05
TOTAL377262045.5220.6140.4320.943
 
CBSSports Facebook Google Plus
COMMENTS
Conversation powered by Livefyre